The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
Open accessAbstract
Infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB), including carbapenem-resistant (CR) Enterobacterales (CRE; harboring mainly blaKPC, blaNDM, and blaOXA-48-like genes), CR- or MDR/XDR-Pseudomonas aeruginosa (production of VIM, IMP, or NDM carbapenemases combined with porin alteration), and Acinetobacter baumannii complex (producing mainly OXA-23, OXA-58-like carbapenemases), have gradually worsened and become a major challenge to public health because of limited antibiotic choice and high case-fatality rates. Diverse MDR/XDR-GNB isolates have been predominantly cultured from inpatients and hospital equipment/settings, but CRE has also been identified in community settings and long-term care facilities. Several CRE outbreaks cost hospitals and healthcare institutions huge economic burdens for disinfection and containment of their disseminations. Parenteral polymyxin B/E has been observed to have a poor pharmacokinetic profile for the treatment of CR- and XDR-GNB. It has been determined that tigecycline is suitable for the treatment of bloodstream infections owing to GNB, with a minimum inhibitory concentration of ≤ 0.5 mg/L. Ceftazidime-avibactam is a last-resort antibiotic against GNB of Ambler class A/C/D enzyme-producers and a majority of CR-P. aeruginosa isolates. Furthermore, ceftolozane-tazobactam is shown to exhibit excellent in vitro activity against CR- and XDR-P. aeruginosa isolates. Several pharmaceuticals have devoted to exploring novel antibiotics to combat these troublesome XDR-GNBs. Nevertheless, only few antibiotics are shown to be effective in vitro against CR/XDR-A. baumannii complex isolates. In this era of antibiotic pipelines, strict implementation of antibiotic stewardship is as important as in-time isolation cohorts in limiting the spread of CR/XDR-GNB and alleviating the worsening trends of resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir202 · Cited by 1,033
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
Bassetti, M., Echols, R., Matsunaga, Y., Ariyasu, M., Doi, Y., Ferrer, R., Lodise, T. P., Naas, T., Niki, Y., Paterson, D. L., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30796-9 · Cited by 828
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Nordmann, P., & Poirel, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz824 · Cited by 721
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Efflux-mediated multiresistance in Gram-negative bacteria
Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 613
Daikos, G. L., Tsaousi, S., Tzouvelekis, L. S., Anyfantis, I., Psichogiou, M., Argyropoulou, A., Stefanou, I., Sypsa, V., Miriagou, V., Nepka, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02166-13 · Cited by 597
Multidrug-Resistant Bacteria in the Community
van Duin, D., & Paterson, D. L. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.004 · Cited by 584
Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
Zhang, R., Liu, L., Zhou, H., Chan, E. W., Li, J., Fang, Y., Li, Y., Liao, K., & Chen, S. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.032 · Cited by 542
Gutiérrez-Gutiérrez, B., Salamanca, E., de Cueto, M., Hsueh, P.-R., Viale, P., Paño-Pardo, J. R., Venditti, M., Tumbarello, M., Daikos, G., Cantón, R., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30228-1 · Cited by 512
Self-citationHirsch, E. B., & Tam, V. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq108 · Cited by 477
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
Hirsch, E. B., & Tam, V. H. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.49 · Cited by 406
Tamma, P. D., Goodman, K. E., Harris, A. D., Tekle, T., Roberts, A., Taiwo, A., & Simner, P. J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw741 · Cited by 402
Kempf, M., & Rolain, J.-M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.10.004 · Cited by 389
Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Borer, A., Saidel-Odes, L., Riesenberg, K., Eskira, S., Peled, N., Nativ, R., Schlaeffer, F., & Sherf, M. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/605922 · Cited by 389
Wang, Q., Wang, X., Wang, J., Ouyang, P., Jin, C., Wang, R., Zhang, Y., Jin, L., Chen, H., Wang, Z., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy660 · Cited by 349
Capone, A., Giannella, M., Fortini, D., Giordano, A., Meledandri, M., Ballardini, M., Venditti, M., Bordi, E., Capozzi, D., Balice, M. P., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12070 · Cited by 346
Treating infections caused by carbapenemase-producing Enterobacteriaceae
Tzouvelekis, L. S., Markogiannakis, A., Piperaki, E., Souli, M., & Daikos, G. L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12697 · Cited by 337
Treatment of Infections Due to MDR Gram-Negative Bacteria
Bassetti, M., Peghin, M., Vena, A., & Giacobbe, D. R. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00074 · Cited by 326
Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates
Tamma, P. D., & Simner, P. J. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-18 · Cited by 293
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
Isler, B., Doi, Y., Bonomo, R. A., & Paterson, D. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01110-18 · Cited by 293
Raman, G., Avendano, E. E., Chan, J., Merchant, S., & Puzniak, L. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-018-0370-9 · Cited by 269
Micek, S. T., Wunderink, R. G., Kollef, M. H., Chen, C., Rello, J., Chastre, J., Antonelli, M., Welte, T., Clair, B., Ostermann, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0926-5 · Cited by 267
Carbapenem-resistant Enterobacteriaceae in the community: a scoping review
Kelly, A. M., Mathema, B., & Larson, E. L. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.012 · Cited by 242
Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment
Piperaki, E.-T., Tzouvelekis, L. S., Miriagou, V., & Daikos, G. L. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.014 · Cited by 240
Lin, M. Y., Lyles-Banks, R. D., Lolans, K., Hines, D. W., Spear, J. B., Petrak, R., Trick, W. E., Weinstein, R. A., Hayden, M. K., Acuna, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit500 · Cited by 226
Mobile Carbapenemase Genes in Pseudomonas aeruginosa
Yoon, E.-J., & Jeong, S. H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.614058 · Cited by 221
Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States
Bartsch, S. M., McKinnell, J. A., Mueller, L. E., Miller, L. G., Gohil, S. K., Huang, S. S., & Lee, B. Y. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.09.003 · Cited by 220
Borer, A., Saidel-Odes, L., Eskira, S., Nativ, R., Riesenberg, K., Livshiz-Riven, I., Schlaeffer, F., Sherf, M., & Peled, N. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.05.022 · Cited by 213
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Bulik, C. C., & Nicolau, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01420-10 · Cited by 200
Karlowsky, J. A., Kazmierczak, K. M., de Jonge, B. L. M., Hackel, M. A., Sahm, D. F., & Bradford, P. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00472-17 · Cited by 194
Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae
McLaughlin, M., Advincula, M. R., Malczynski, M., Qi, C., Bolon, M., & Scheetz, M. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00607-13 · Cited by 191
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli
Takahata, S., Ida, T., Hiraishi, T., Sakakibara, S., Maebashi, K., Terada, S., Muratani, T., Matsumoto, T., Nakahama, C., & Tomono, K. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.011 · Cited by 191
Yamano, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz827 · Cited by 191
Tilahun, M., kassa, Y., Gedefie, A., & Belete, M. A. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s337611 · Cited by 190
Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
Pires, D. P., Vilas Boas, D., Sillankorva, S., & Azeredo, J. (2015) · Journal of Virology · doi:10.1128/jvi.00385-15 · Cited by 185
Falagas, M. E., Kastoris, A. C., Vouloumanou, E. K., Rafailidis, P. I., Kapaskelis, A. M., & Dimopoulos, G. (2009) · Future Microbiology · doi:10.2217/fmb.09.84 · Cited by 179
Ackley, R., Roshdy, D., Meredith, J., Minor, S., Anderson, W. E., Capraro, G. A., & Polk, C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02313-19 · Cited by 170
Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia
Jean, S., Chang, Y.-C., Lin, W.-C., Lee, W., Hsueh, P., & Hsu, C.-W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010275 · Cited by 167
Self-citationKengkla, K., Kongpakwattana, K., Saokaew, S., Apisarnthanarak, A., & Chaiyakunapruk, N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx368 · Cited by 164
Morata, L., Cobos-Trigueros, N., Martínez, J. A., Soriano, Á., Almela, M., Marco, F., Sterzik, H., Núñez, R., Hernández, C., & Mensa, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00750-12 · Cited by 163
W. S. Yapa, S., Li, J., Patel, K., Wilson, J. W., Dooley, M. J., George, J., Clark, D., Poole, S., Williams, E., Porter, C. J. H., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01705-13 · Cited by 161
Hellyer, T. P., Ewan, V. C., Wilson, P., & Simpson, A. J. (2016) · Journal of the Intensive Care Society · doi:10.1177/1751143716644461 · Cited by 156
Goodman, K., Simner, P. J., Tamma, P. D., & Milstone, A. M. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2016.1106940 · Cited by 153
Jaruratanasirikul, S., Sriwiriyajan, S., & Punyo, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1337-1339.2005 · Cited by 149
Abdellatif, S., Trifi, A., Daly, F., Mahjoub, K., Nasri, R., & Lakhal, S. B. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0127-7 · Cited by 148
holt, A. F. V. I. ’., Severin, J. A., Lesaffre, E. M. E. H., & Vos, M. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01758-13 · Cited by 146
Avison, M. B., Higgins, C. S., von Heldreich, C. J., Bennett, P. M., & Walsh, T. R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.413-419.2001 · Cited by 146
Shields, R. K., Clancy, C. J., Gillis, L. M., Kwak, E. J., Silveira, F. P., Abdel-Massih, R. C., Eschenauer, G. A., Potoski, B. A., & Nguyen, M. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052349 · Cited by 144
Biedenbach, D. J., Kazmierczak, K. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-15 · Cited by 141
Sader, H. S., Huband, M. D., Castanheira, M., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02252-16 · Cited by 141
Jean, S., Lee, W., Lam, C., Hsu, C.-W., Chen, R., & Hsueh, P. (2015) · Future Microbiology · doi:10.2217/fmb.14.135 · Cited by 137
Self-citationSheng, W., Liao, C., Lauderdale, T.-L. Y., Ko, W., Chen, Y.-S., Liu, J.-W., Lau, Y.-J., Wang, L.-S., Liu, K.-S., Tsai, T.-Y., et al. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.02.2254 · Cited by 136
Lübbert, C., Becker-Rux, D., Rodloff, A. C., Laudi, S., Busch, T., Bartels, M., & Kaisers, U. X. (2013) · Infection · doi:10.1007/s15010-013-0547-3 · Cited by 134
Cheng, A., Chuang, Y., Sun, H., Sheng, W., Yang, C., Liao, C., Hsueh, P., Yang, J., Shen, N.-J., Wang, J., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000933 · Cited by 128
Self-citationPoulikakos, P., Tansarli, G. S., & Falagas, M. E. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2124-9 · Cited by 125
Papp‐Wallace, K. M., Bethel, C. R., Caillon, J., Barnes, M. D., Potel, G., Bajaksouzian, S., Rutter, J. D., Reghal, A., Shapiro, S., Taracila, M. A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00105-19 · Cited by 120
AStenotrophomonas maltophiliaMultilocus Sequence Typing Scheme for Inferring Population Structure
Kaiser, S., Biehler, K., & Jonas, D. (2009) · Journal of Bacteriology · doi:10.1128/jb.00892-08 · Cited by 117
Jefferies, J. M., Cooper, T., Yam, T., & Clarke, S. C. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.044818-0 · Cited by 116
Morrissey, I., Magnet, S., Hawser, S., Shapiro, S., & Knechtle, P. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00514-19 · Cited by 115
Yin, D., Wu, S., Yang, Y., Shi, Q., Dong, D., Zhu, D., & Hu, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02431-18 · Cited by 110
The Emerging Threat of Multidrug-Resistant Gram-Negative Organisms in Long-Term Care Facilities
O’Fallon, E., Pop-Vicas, A. E., & D’Agata, E. M. C. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/gln020 · Cited by 108
Hsueh, S.-C., Lee, Y., Huang, Y., Liao, C., Tsuji, M., & Hsueh, P. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky425 · Cited by 108
Self-citationTran, D. M., Larsson, M., Olson, L., Hoang, N. T. B., Le, N. K., Khu, D. T. K., Nguyen, H. D., Vu, T. V., Trinh, T. H., Le, T. Q., et al. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.05.013 · Cited by 105
Bhargava, A., Hayakawa, K., Silverman, E., Haider, S., Alluri, K., Datla, S., Diviti, S., Kuchipudi, V., Muppavarapu, K. S., Lephart, P., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675614 · Cited by 103
PASCALE, G. D., Martucci, G., Montini, L. M., Panarello, G., Cutuli, S. L., Carlo, D. D., Gravio, V. D., Stefano, R. D., Capitanio, G., Vallecoccia, M. S., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1769-z · Cited by 103
VIM-1 Metallo-β-lactamase inAcinetobacter baumannii
Tsakris, A., Ikonomidis, A., Pournaras, S., TZOUVELEKIS, L. S., Sofianou, D., Legakis, N. J., & Maniatis, A. N. (2006) · Emerging infectious diseases · doi:10.3201/eid1206.051097 · Cited by 101
Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel
Ben-David, D., Masarwa, S., Navon‐Venezia, S., Mishali, H., Fridental, I., Rubinovitch, B., Smollan, G., Carmeli, Y., Schwaber, M. J., & Israel PACF CRKP (Post-Acute-Care Facility Carbapenem-Resistant Klebsiella pneumoniae) Working Group (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/661279 · Cited by 98
Shapiro, A. B., Moussa, S. H., McLeod, S. M., Durand-Réville, T. F., & Miller, A. A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.709974 · Cited by 97
Vestergaard, M. R., Paulander, W., Marvig, R. L., Clasen, J., Jochumsen, N., Molin, S., Jelsbak, L., Ingmer, H., & Folkesson, A. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.09.014 · Cited by 95
Lee, Y.-C., Huang, Y., Tan, C., Kuo, Y.-W., Liao, C., Lee, P., & Hsueh, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr200 · Cited by 90
Self-citationWang, J., Zhou, J., Qu, T., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.014 · Cited by 89
Kawai, A., McElheny, C. L., Iovleva, A., Kline, E. G., Sluis‐Cremer, N., Shields, R. K., & Doi, Y. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00198-20 · Cited by 87
Phage Abp1 Rescues Human Cells and Mice from Infection by Pan-Drug Resistant Acinetobacter Baumannii
Yin, S., Huang, G., Zhang, Y., Jiang, B., Yang, Z., Dong, Z.-W., You, B. R., Yuan, Z., Hu, F., Zhao, Y., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000486117 · Cited by 86
Sader, H. S., Castanheira, M., Mendes, R. E., & Flamm, R. K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky279 · Cited by 86
Kateete, D. P., Nakanjako, R., Namugenyi, J., Erume, J., Joloba, M. L., & Najjuka, C. F. (2016) · SpringerPlus · doi:10.1186/s40064-016-2986-7 · Cited by 84
Kanamori, H., Parobek, C. M., Juliano, J. J., van Duin, D., Cairns, B. A., Weber, D. J., & Rutala, W. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01516-16 · Cited by 83
Alraddadi, B. M., Saeedi, M. F., Qutub, M., Alshukairi, A. N., Hassanien, A., & Wali, G. Y. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4409-1 · Cited by 82
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
International Society of Antimicrobial Chemotherapy (ISAC), Jean, S., Gould, I. M., Lee, W., & Hsueh, P. (2019) · Drugs · doi:10.1007/s40265-019-01112-1 · Cited by 80
Self-citationSader, H. S., Castanheira, M., Huband, M. D., Jones, R. N., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00072-17 · Cited by 79
Tavoschi, L., Forni, S., Porretta, A. D., Righi, L., Pieralli, F., Menichetti, F., Falcone, M., Gemignani, G., Sani, S., Vivani, P., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.6.2000085 · Cited by 79
McKinnell, J. A., Singh, R. D., Miller, L. G., Kleinman, K., Gussin, G., He, J., Saavedra, R., Dutciuc, T. D., Estevez, M., Chang, J., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz119 · Cited by 76
Sader, H. S., Carvalhaes, C. G., Arends, S. J. R., Castanheira, M., & Mendes, R. E. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa504 · Cited by 76
Pannaraj, P. S., Bard, J. D., Cerini, C., & Weissman, S. J. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000471 · Cited by 75
Wang, L., di Luca, M., Tkhilaishvili, T., Trampuz, A., & González-Moreno, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02522 · Cited by 75
Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis
de Matos, E. C. O., Andriolo, R. B., Rodrigues, Y. C., de Lima, P. D. L., Carneiro, I. C. D. R. S., & Lima, K. V. B. (2018) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0506-2017 · Cited by 71
Lowings, M., Ehlers, M. M., Dreyer, A. W., & Kock, M. M. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1246-8 · Cited by 68
Karlowsky, J. A., Hackel, M., Bouchillon, S. K., & Sahm, D. F. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01432-20 · Cited by 68
Mills, J., Talati, N. J., Alby, K., & Han, J. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.254 · Cited by 64
Code blue: A cinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity
Richards, A. M., Kwaik, Y. A., & Lamont, R. J. (2014) · Molecular Oral Microbiology · doi:10.1111/omi.12072 · Cited by 63
Kang, C., Chen, X., Chih, C.-C., Hsu, C.-C., Chen, P., Lee, T. F., Teng, L., & Hsueh, P. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.03.018 · Cited by 63
Self-citationBarnes, M. D., Taracila, M. A., Good, C. E., Bajaksouzian, S., Rojas, L. J., van Duin, D., Kreiswirth, B. N., Jacobs, M. R., Haldimann, A., Papp‐Wallace, K. M., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00432-19 · Cited by 62
Boyd, N. K., & Nailor, M. D. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.11.1073 · Cited by 61
Kao, C., Chen, S.-S., Hung, K., Wu, H.-M., Hsueh, P., Yan, J.-J., & Wu, J.-J. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0719-2 · Cited by 59
Self-citationTang, H.-J., Hsieh, C., Chang, P., Chen, J.-J., Lin, Y., Lai, C., Chao, C., & Chuang, Y.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151897 · Cited by 58
Giufrè, M., Ricchizzi, E., Accogli, M., Barbanti, F., Monaco, M., de Araujo, F. P., Farina, C., Fazii, P., Mattei, R., Sarti, M., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.04.006 · Cited by 58
Chen, C., Lai, C., Huang, H.-L., Su, Y.-T., Chiu, Y.-H., Toh, H. S., Chiang, S., Chuang, Y.-C., Lu, Y.-C., & Tang, H.-J. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.01.005 · Cited by 57
Statewide Surveillance of Carbapenem-Resistant Enterobacteriaceae in Michigan
Brennan, B. M., Coyle, J. R., Marchaim, D., Pogue, J. M., Boehme, M. S., Finks, J. L., Malani, A. N., VerLee, K. E., Buckley, B. O., Mollon, N., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675611 · Cited by 56
Lapointe‐Shaw, L., Voruganti, T., Kohler, P. P., Thein, H., Sander, B., & McGeer, A. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2890-7 · Cited by 56
Zaidah, A. R., Mohammad, N. I., Suraiya, S., & Harun, A. B. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0200-5 · Cited by 56
Wang, X., Zhao, C., Wang, Q., Wang, Z., Liang, X., Zhang, F., Zhang, Y., Meng, H., Chen, H., Li, S., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa053 · Cited by 56
Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
Bounthavong, M., Hsu, D. I., & Hong, M.-C. (2013) · Infection and Drug Resistance · doi:10.2147/idr.s36140 · Cited by 55
Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
Jean, S., Lee, N., Tang, H.-J., Lu, M.-C., Ko, W., & Hsueh, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02888 · Cited by 55
Self-citationVijayakumar, S., Gopi, R., Gunasekaran, P., Bharathy, M., Walia, K., Anandan, S., & Veeraraghavan, B. (2016) · Infectious Diseases and Therapy · doi:10.1007/s40121-016-0125-y · Cited by 54
Tselepis, L., Langley, G. W., Aboklaish, A. F., Widlake, E., Jackson, D. E., Walsh, T. R., Schofield, C. J., Brem, J., & Tyrrell, J. M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105925 · Cited by 54
Jean, S., Lee, Y.-L., Liu, P., Lu, M., Ko, W., & Hsueh, P. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.07.015 · Cited by 53
Self-citationEmergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France
Benzerara, Y., Gallah, S., Hommeril, B., Genel, N., Decré, D., Rottman, M., & Arlet, G. (2017) · Emerging infectious diseases · doi:10.3201/eid2309.170560 · Cited by 51
Liu, P., Ko, W., Lee, W., Lu, P., Chen, Y., Cheng, S., Lu, M., Lin, C., Wu, T., Yen, M., et al. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.08.012 · Cited by 51
Self-citationAtti, M. L. C. D., Bernaschi, P., Carletti, M., Luzzi, I., García-Fernández, A., Bertaina, A., Sisto, A., Locatelli, F., & Raponi, M. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-494 · Cited by 49
Schäfer, E., Malecki, M., Téllez‐Castillo, C. J., Pfennigwerth, N., Marlinghaus, L., Higgins, P. G., Mattner, F., & Wendel, A. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0665-5 · Cited by 49
Kuo, S., Wang, Y.-C., Tan, M.-C., Huang, W., Shiau, Y., Wang, H., Lai, J., Huang, I., & Lauderdale, T.-L. Y. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab141 · Cited by 46
McCracken, M., Adam, H. J., Blondeau, J. M., Walkty, A. J., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G., Mulvey, M. R., Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD, Zhanel, G. G., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz285 · Cited by 45
Amladi, A. U., Abirami, B., Devi, S. M., Sudarsanam, T. D., Kandasamy, S., Kekre, N. S., Veeraraghavan, B., & Sahni, R. D. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2086_17 · Cited by 43
Nucleo, E., Caltagirone, M., Marchetti, V. M., D’Angelo, R., Fogato, E., Confalonieri, M., Reboli, C., March, A., Sleghel, F., Soelva, G., et al. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0326-0 · Cited by 42
Le, M. N., Kayama, S., Yoshikawa, M., Hara, T., Kashiyama, S., Hisatsune, J., Tsuruda, K., Onodera, M., Ohge, H., Tsuga, K., et al. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-0705-1 · Cited by 42
Jean, S., Hsieh, T.-C., Hsu, C.-W., Lee, W., Bai, K., & Lam, C. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2015.06.009 · Cited by 41
Self-citationMoubareck, C. A., Halat, D. H., Akkawi, C., Nabi, A., Al-Sharhan, M., AlDeesi, Z. O., Peters, C. C., Celiloglu, H., & Sarkis, D. K. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.04.027 · Cited by 40
Asempa, T. E., Motos, A., Abdelraouf, K., Bissantz, C., Zampaloni, C., & Nicolau, D. P. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.10.019 · Cited by 40
de Man, T. J. B., Yaffee, A. Q., Zhu, W., Batra, D. G., Alyanak, E., Rowe, L. A., McAllister, G. A., Moulton-Meissner, H. A., Boyd, S., Flinchum, A. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa049 · Cited by 39
Yoon, Y. K., Yang, K., Lee, S. E., Kim, H. J., Sohn, J. W., & Kim, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099101 · Cited by 38
Wang, T.-H., Leu, Y., Wang, N., Liu, C.-P., & Yan, T. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0410-5 · Cited by 38
Chowdhury, P. R., Scott, M. J., & Djordjevic, S. P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw471 · Cited by 37
Tang, H.-J., Lai, C.-C., Chen, C.-C., Zhang, C.-C., Weng, T., Chiu, Y.-H., Toh, H. S., Chiang, S., Yu, W.-L., Ko, W., et al. (2016) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.03.003 · Cited by 34
Ezadi, F., Jamali, A., Heidari, A., Javid, N., & Ardebili, A. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.11.010 · Cited by 34
Hayakawa, K., Nakano, R., Hase, R., Shimatani, M., Kato, H., Hasumi, J., Doi, A., Sekiya, N., Nei, T., Okinaka, K., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz501 · Cited by 34
Zhang, H., Zhang, G., Yang, Y., Zhang, J., Li, D., Duan, S., Yang, Q., & Xu, Y. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.03.009 · Cited by 31
Al-Fadhli, A. H., Jamal, W. Y., & Rotimi, V. O. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241971 · Cited by 30
Li, J., Bi, W., Dong, G., Zhang, Y., Wu, Q., Dong, T., Cao, J., & Zhou, T. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.12.013 · Cited by 28
Neidhöfer, C., Buechler, C., Neidhöfer, G., Bierbaum, G., Hannet, I., Hoerauf, A. M., & Parčina, M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.659753 · Cited by 28
Wang, C.-H., Ma, L., Huang, L.-Y., Yeh, K., Lin, J., Siu, L.-K. K., & Chang, F. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.04.006 · Cited by 27
Lin, Y.-T., Su, C.-F., Chuang, C., Lin, J., Lu, P., Huang, C.-T., Wang, J., Chuang, Y.-C., Siu, L.-K. K., & Fung, C.-P. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy336 · Cited by 26
Jean, S., Ko, W., Lu, M., Lee, W., & Hsueh, P. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2021876 · Cited by 24
Self-citationZhang, H., Jia, P., Zhu, Y., Zhang, G., Zhang, J., Kang, W., Duan, S., Zhang, W., Yang, Q., & Xu, Y. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s325520 · Cited by 21
́Cortivo, G. D., Gutberlet, A., Ferreira, J. A., Ferreira, L. E., Deglmann, R. C., Westphal, G. A., & de França, P. H. C. (2015) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0233-2015 · Cited by 19
Urzêdo, J. E., Menezes, R. D. P., Porto, J. P., Ferreira, M. L., Rossi, I., de Brito, C. S., Gontijo-Filho, P. P., & Ribas, R. M. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001273 · Cited by 16
Reuben, J., Donegan, N., Wortmann, G. W., DeBiasi, R. L., Song, X., Kumar, P. N., McFadden, M. M., Clagon, S., Mirdamadi, J., White, D., et al. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.110 · Cited by 15
Loose, M., Link, I., Naber, K. G., & Wagenlehner, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01839-19 · Cited by 10
An evaluation of meropenem/vaborbactam for the treatment of nosocomial pneumonia
Groft, L., Claeys, K. C., & Heil, E. L. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1840552 · Cited by 8
Cited by
Sati, H., Carrara, E., Savoldi, A., Hansen, P., Garlasco, J., Campagnaro, E., Boccia, S., Castillo-Polo, J. A., Magrini, E., Garcia-Vello, P., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00118-5 · Cited by 882
Mbabazi, L., Hahn, S., Sserubiri, L., Natukunda, P., Wamawobe, A., Kajumbula, H., Nakate, V., Lübbert, C., Musaazi, J., Nabajja, H., et al. (2025) · BMC Women's Health · doi:10.1186/s12905-025-04101-7 · Cited by 4
Metadata
- Authors
- Jean, S.-S., Harnod, D., & Hsueh, P.-R.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-03-15
- Volume
- 12
- Pages
- 823684-823684
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W4220992333
- Cited by
- 366
- References
- 143
- FWCI
- 19.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.